Who is the CEO of OncoSil Medical Limited?

The CEO of OncoSil Medical Limited is Nigel Lange.

What industry does OncoSil Medical Limited belong to?

OncoSil Medical Limited operates in the Medical - Devices industry within the Healthcare sector.

Where is OncoSil Medical Limited headquartered?

OncoSil Medical Limited is headquartered at 15 Blue Street, Macquarie Park, NSW, 2060, AU.

What is the IPO date of OncoSil Medical Limited?

OncoSil Medical Limited went public on August 15, 2005.

How many employees does OncoSil Medical Limited have?

OncoSil Medical Limited has approximately 2 full-time employees.

OncoSil Medical Limited

OSL.AX•ASX

Healthcare

Medical - Devices

A$1.08

A$0.01(0.93%)

OncoSil Medical Limited (OSL.AX) Company Profile & Overview

Explore OncoSil Medical Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

OncoSil Medical Limited (OSL.AX) Company Profile & Overview

OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorporated in 2005 and is headquartered in North Sydney, Australia.

SectorHealthcare

IndustryMedical - Devices

CEONigel Lange

Contact Information

https://www.oncosil.com.au

61 2 9223 3344

15 Blue Street, Macquarie Park, NSW, 2060

Company Facts

2 Employees

IPO DateAug 15, 2005

CountryAU

Actively Trading

Frequently Asked Questions

;